What is NanoViricides Inc.'s Market Cap?

NanoViricides Inc.'s Market Cap is $23.4M, based on as-reported figures from SEC (XBRL) filings.

What is NanoViricides Inc.'s Enterprise Value?

NanoViricides Inc.'s Enterprise Value is $20.2M, based on as-reported figures from SEC (XBRL) filings.

What is NanoViricides Inc.'s EV / EBITDA?

NanoViricides Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is NanoViricides Inc.'s Revenue (TTM)?

NanoViricides Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is NanoViricides Inc.'s Net Income (TTM)?

NanoViricides Inc.'s Net Income (TTM) is -$8.1M, based on as-reported figures from SEC (XBRL) filings.

What is NanoViricides Inc.'s EBITDA?

NanoViricides Inc.'s EBITDA is -$7.6M, based on as-reported figures from SEC (XBRL) filings.

What is NanoViricides Inc.'s Diluted EPS (TTM)?

NanoViricides Inc.'s Diluted EPS (TTM) is -0.37, based on as-reported figures from SEC (XBRL) filings.

What is NanoViricides Inc.'s Net Debt?

NanoViricides Inc.'s Net Debt is -$3.2M, based on as-reported figures from SEC (XBRL) filings.

NanoViricides Inc. (NNVC) Financial Statements

NanoViricides Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SDFF62

XASE · usd

1.08▼ 0.04 (-3.57%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.12

Day's Range1.08 – 1.13

52-Week Range0.85 – 2.23

Volume260.5K

Avg Volume287.8K

Share Statistics

Shares Outstanding

Employees7

ExchangeXASE

Listed2005-07-05

Share count as of May 14, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about NanoViricides Inc. (NNVC)

What is NanoViricides Inc.'s Market Cap?: NanoViricides Inc.'s Market Cap is $23.4M, based on as-reported figures from SEC (XBRL) filings.
What is NanoViricides Inc.'s Enterprise Value?: NanoViricides Inc.'s Enterprise Value is $20.2M, based on as-reported figures from SEC (XBRL) filings.
What is NanoViricides Inc.'s EV / EBITDA?: NanoViricides Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is NanoViricides Inc.'s Revenue (TTM)?: NanoViricides Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is NanoViricides Inc.'s Net Income (TTM)?: NanoViricides Inc.'s Net Income (TTM) is -$8.1M, based on as-reported figures from SEC (XBRL) filings.
What is NanoViricides Inc.'s EBITDA?: NanoViricides Inc.'s EBITDA is -$7.6M, based on as-reported figures from SEC (XBRL) filings.
What is NanoViricides Inc.'s Diluted EPS (TTM)?: NanoViricides Inc.'s Diluted EPS (TTM) is -0.37, based on as-reported figures from SEC (XBRL) filings.
What is NanoViricides Inc.'s Net Debt?: NanoViricides Inc.'s Net Debt is -$3.2M, based on as-reported figures from SEC (XBRL) filings.